Suppr超能文献

四方片和金匮肾气丸对糖尿病肾病患者肠道菌群及代谢的影响。

Effects of tetragonum tablets and Jin Gui Ren Qi Pill on intestinal flora and metabolism in patients with diabetic kidney disease.

作者信息

Zhang Cheng-Yu, Yue Dong-Jie, Wang Di, Wu Fei-Fei

机构信息

Department of Endocrinology and Metabolism, The Fifth People's Hospital of Chongqing, Chongqing, China.

Zhengzhou Second People's Hospital, Zhengzhou City, Henan Province, China.

出版信息

Front Pharmacol. 2024 Jul 29;15:1346168. doi: 10.3389/fphar.2024.1346168. eCollection 2024.

Abstract

OBJECTIVE

To investigate the effects of tetragonum tablets and Jin Gui Ren Qi Pill on intestinal flora and metabolism in patients with diabetic kidney disease.

METHODS

In the study conducted at Heping Hospital of Changzhi Medical College from March 2021 to December 2022, 30 cases of patients diagnosed with diabetic nephropathy were meticulously selected as study subjects. Employing a double-blind randomized table method, these patients were randomly allocated into three groups: the control group (n = 10), the tetragonum tablets group (n = 10), and the Jin Gui Ren Qi Pill group (n = 10). The control group received standard western medical treatments for diabetic nephropathy, including serum glucose, blood lipids, blood pressure management, and other conventional therapies. In addition to the standard treatments, the tetragonum tablets group received tetragonum tablets, while the Jin Gui Ren Qi Pill group received Jin Gui Ren Qi Pill. Before and after a 4-week treatment period, various baseline parameters were assessed, including fasting blood glucose, 2-h postprandial blood glucose, triglycerides, serum total cholesterol, serum low-density lipoprotein cholesterol, serum high-density lipoprotein cholesterol, random urine microalbumin/creatinine ratio (ACR), blood creatinine (SCr), and traditional Chinese medicine evidence scores. Stool specimens were collected from all three groups before and after treatment for 16S rDNA high-throughput sequencing, followed by comprehensive analyses including OUT clustering, Alpha diversity, Beta diversity, species composition analysis, LEfSe analysis, and KEGG function prediction. Spearman correlation analysis was employed to explore the relationship between intestinal flora and clinical indicators. Furthermore, fasting peripheral venous blood was collected from patients in the Bifidobacterium tetrapunctate tablets group and the control group before and after intervention to measure the optical density values of tumor necrosis factor-α (TNF-α), interleukin-2 (IL-2), and interleukin-6 (IL-6) using the Beijing Biolite ELISA kit. This study was conducted with the approval of the Ethics Committee of Changzhi Medical College.

RESULTS

  1. The 2hPBG, total cholesterol and LDL levels were observed among patients with diabetic kidney disease (DKD) across all groups: the Jin Gui Ren Qi Pill group, the tetragonum tablets group, and the control group ( < 0.05). 2. The Jin Gui Ren Qi Pill demonstrated superior efficacy in alleviating TCM symptoms and reducing the ACR compared to both the tetragonum tablets group and the control group. Conversely, tetragonum tablets exhibited a more pronounced reduction in TC levels compared to both the Jin Gui Ren Qi Pill and control groups. Notably, tetragonum tablets effectively decreased (IL-2) levels in patients with DKD. 3. tetragonum tablets also demonstrated efficacy in reducing IL-2 levels in DKD patients. 4. Analysis of intestinal microorganism abundance and diversity before and after the intervention, as well as among the three groups, revealed no significant alterations. Similarly, comparisons of ACE, Chao, Simpson, and Shannon indices showed no statistically significant differences ( > 0.05). 5. Qualitative analysis of intestinal microorganisms before and after intervention, as well as among the three groups, indicated no significant differences. Anosim test results also did not reveal qualitative distinctions (Anosim test R = 0.021, = 0.215). 6. LEfSe analysis unveiled a noteworthy increase in Prevotella_7 abundance within the Jin Gui Ren Qi Pill group post-intervention ( < 0.05). 7. Furthermore, Chinese medicine evidence scores, body mass index, TC, and LDL levels correlated positively with the relative abundance of Tyzzerella_3 bacterial flora. Conversely, age, disease duration, and 2hPBG correlated positively with the relative abundance of Christensenellaceae_R_7 flora, while TC and LDL levels displayed a negative correlation with the relative abundance of Christensenellaceae_R_7 flora.

CONCLUSION

The combination of Jin Gui Ren Qi Pill with western medical treatment exhibited superior efficacy in ameliorating clinical symptoms and reducing the ACR in patients with DKD compared to western medical treatment alone. Furthermore, this combination therapy led to an increase in the abundance of Prevotella_7 within the intestinal flora of patients, suggesting a potential enhancement in carbohydrate metabolism by the intestinal microbiota. On the other hand, tetragonum tablets bacterial tablets combined with western medical treatment demonstrated enhanced efficacy in reducing TC levels in DKD patients compared to western medical treatment alone. Additionally, this combination therapy effectively reduced the levels of IL-2 in DKD patients, thus mitigating inflammation in these individuals.

摘要

目的

探讨复方四君子片和金匮肾气丸对糖尿病肾病患者肠道菌群及代谢的影响。

方法

在长治医学院和平医院于2021年3月至2022年12月开展的研究中,精心选取30例确诊为糖尿病肾病的患者作为研究对象。采用双盲随机表法,将这些患者随机分为三组:对照组(n = 10)、复方四君子片组(n = 10)和金匮肾气丸组(n = 10)。对照组接受糖尿病肾病的标准西医治疗,包括血糖、血脂、血压管理及其他常规疗法。除标准治疗外,复方四君子片组服用复方四君子片,金匮肾气丸组服用金匮肾气丸。在4周治疗期前后,评估各项基线参数,包括空腹血糖、餐后2小时血糖、甘油三酯、血清总胆固醇、血清低密度脂蛋白胆固醇、血清高密度脂蛋白胆固醇、随机尿微量白蛋白/肌酐比值(ACR)、血肌酐(SCr)以及中医证候评分。收集三组治疗前后的粪便标本进行16S rDNA高通量测序,随后进行包括OUT聚类、Alpha多样性、Beta多样性、物种组成分析、LEfSe分析和KEGG功能预测的综合分析。采用Spearman相关性分析探讨肠道菌群与临床指标之间的关系。此外,在双歧杆菌四联片组和对照组干预前后采集空腹外周静脉血,使用北京博奥联免疫吸附测定试剂盒测量肿瘤坏死因子-α(TNF-α)、白细胞介素-2(IL-2)和白细胞介素-6(IL-6)的光密度值。本研究经长治医学院伦理委员会批准。

结果

  1. 在所有组的糖尿病肾病(DKD)患者中观察到餐后2小时血糖、总胆固醇和低密度脂蛋白水平:金匮肾气丸组、复方四君子片组和对照组(<0.05)。2. 与复方四君子片组和对照组相比,金匮肾气丸在缓解中医症状和降低ACR方面显示出更好的疗效。相反,与金匮肾气丸组和对照组相比,复方四君子片在降低总胆固醇水平方面表现更为显著。值得注意的是,复方四君子片有效降低了DKD患者的(IL-2)水平。3. 复方四君子片在降低DKD患者IL-2水平方面也显示出疗效。4. 干预前后及三组之间肠道微生物丰度和多样性分析显示无显著变化。同样,ACE、Chao、Simpson和Shannon指数的比较也未显示出统计学显著差异(>0.05)。5. 干预前后及三组之间肠道微生物的定性分析表明无显著差异。Anosim检验结果也未揭示定性差异(Anosim检验R = 0.021,= 0.215)。6. LEfSe分析显示,干预后金匮肾气丸组中普雷沃氏菌_7丰度显著增加(<0.05)。7. 此外,中医证候评分、体重指数、总胆固醇和低密度脂蛋白水平与泰泽氏菌_3菌群的相对丰度呈正相关。相反,年龄、病程和餐后2小时血糖与科里森氏菌_R_7菌群的相对丰度呈正相关,而总胆固醇和低密度脂蛋白水平与科里森氏菌_R_7菌群的相对丰度呈负相关。

结论

与单纯西医治疗相比,金匮肾气丸联合西医治疗在改善DKD患者临床症状和降低ACR方面显示出更好的疗效。此外,这种联合治疗导致患者肠道菌群中普雷沃氏菌_7丰度增加,提示肠道微生物群对碳水化合物代谢的潜在增强作用。另一方面,复方四君子片联合西医治疗与单纯西医治疗相比,在降低DKD患者总胆固醇水平方面显示出增强的疗效。此外,这种联合治疗有效降低了DKD患者的IL-2水平,从而减轻了这些个体的炎症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04f1/11319841/24e0a4cba868/fphar-15-1346168-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验